Early-Invasive Strategies for the Management of Coronary Heart Disease in Chronic Kidney Disease: Is Acute Kidney Injury a Consideration?
People with chronic kidney disease (CKD) are less likely to receive early-invasive management of acute coronary syndrome (ACS). The purpose of this article is to review the risks and outcomes of early-invasive versus conservative strategies, and to consider how contrast-induced acute kidney injury (CI-AKI) should factor in treatment decisions for people with CKD.
Combined Use of Adipose Derived Stem Cells & Platelet Rich Plasma: Expanding Indications (EP Video)
Dr. Randy Miller amazes the audience with his innovative use for adipose and PRP in plastic surgery (50:00 minutes).
High Dose of N-Acetylcystein Prevents Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Myocardial Revascularization
The renoprotective effect of N-acetylcystein in patients undergoing coronary artery bypass graft surgery is controversial.
Impact of Continuous Deterioration of Kidney Function 6 to 8 Months After Percutaneous Coronary Intervention for Acute Coronary Syndrome
Preprocedural chronic kidney disease and contrast-induced acute kidney injury are predictors of in-hospital death and long-term mortality. However, neither the time course of kidney function after percutaneous coronary intervention (PCI) nor the relation between the time course of kidney function and prognosis has been adequately studied.
A Combined Ultrafiltration Strategy During Pediatric Cardiac Surgery: A Prospective, Randomized, Controlled Study with Clinical Outcomes
The combined use of ultrafiltration of prime solution, zero-balance ultrafiltration, and MUF strategy is associated with a modest improvement in pulmonary function compared with the combination of conventional and MUF strategies in the early postoperative period, but the principal clinical outcomes are similar.
Red Cell Transfusion Management for Patients Undergoing Cardiac Surgery for Congenital Heart Disease
In this study we evaluate the effects of red cell transfusion on mortality and morbidity on patients with congenital heart disease at the time of cardiac surgery.
Five-Year Experience with Mini-Volume Priming in Infants ≤5 kg: Safety of Significantly Smaller Transfusion Volumes
This retrospective study was designed to compare safety and transfusion volumes between the mini-volume priming (MP) and conventional priming (CP) methods.
Management of Perioperative Heart Failure
This review aims to provide conceptual framework by selectively presenting recent knowledge and advances in acute heart failure therapies including drugs (inotropes, diuretics) and devices (mechanical assistance, biventricular pacing, ultrafiltration).
Myocardial Protection in Cardiac Surgery: A Historical Review from the Beginning to the Current Topics
This historical review summarized experimental and clinical studies
Understanding Innovations in the Evolving Practice of Blood and Crystalloid Cardioplegia
We highlight areas of study that have demonstrated a new concept of myocardial protection